FDI in Pharma Industry: Issues & Prospects

In Depth

FDI in Pharma Industry: Issues & Prospects

Sheela Vadavalli | January 2012

This content is restricted to premium members only.

About Author

Sheela Vadavalli

The author is Vice President Legal and Compliance Officer, Mylan Pharmaceuticals, India

The Grand Masters - A Corporate Counsel Legal Best Practices Summit Series

www.grandmasters.in | 8 Years & Counting

The Real Estate & Construction Legal Summit

www.rcls.in | 8 Years & Counting

The Information Technology Legal Summit

www.itlegalsummit.com | 8 Years & Counting

The Banking & Finance Legal Summit

www.bfls.in | 8 Years & Counting

The Media, Advertising and Entertainment Legal Summit

www.maels.in | 8 Years & Counting

The Pharma Legal & Compliance Summit

www.plcs.co.in | 8 Years & Counting

We at Lex Witness strategically assist firms in reaching out to the relevant audience sets through various knowledge sharing initiatives. Here are some more info decks for you to know us better.